Sub Banner Image

Hologic's International Momentum Takes Shape: Will Execution Pay Off?

Equities

Zacks Investment Research

·

July 24, 2025

·

Barchart

International expansion continues to play a central role in Hologic’s HOLX growth strategy. Currently, it generates around 25% of its total revenues from outside the United States — a lower proportion compared to other medical technology companies. Over the past decade, the company has made targeted investments toward international expansion...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.